Antagonizing integrin beta3 increases immune suppression in cancer

Integrin beta3 is critical for tumor invasion, neoangiogenesis, and inflammation making it a promising cancer target. However, preclinical and clinical data of integrin beta3 antagonists have demonstrated no benefit or worse outcomes. We hypothesized that integrin beta3 could affect tumor immunity a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Res
Main Authors: Su, Xinming, Esser, Alison K., Amend, Sarah R., Xiang, Jingyu, Xu, Yalin, Ross, Michael H, Fox, Gregory C., Kobayashi, Takayuki, Steri, Veronica, Roomp, Kirsten, Fontana, Francesca, Hurchla, Michelle A., Knolhoff, Brett L., Meyer, Melissa A., Morgan, Elizabeth A., Tomasson, Julia C., Novack, Joshua S., Zou, Wei, Faccio, Roberta, Novack, Deborah V., Robinson, Stephen D., Teitelbaum, Steven L., DeNardo, David G., Schneider, Jochen G., Weilbaecher, Katherine N.
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4944657/
https://ncbi.nlm.nih.gov/pubmed/27216180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-15-2663
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares